Cite
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations
MLA
Florian Hohla, et al. “Therapy of Ovarian Cancers with Targeted Cytotoxic Analogs of Bombesin, Somatostatin, and Luteinizing Hormone-Releasing Hormone and Their Combinations.” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, June 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....360f343bf96216d6a676c00600b342ca&authtype=sso&custid=ns315887.
APA
Florian Hohla, Elmar Heinrich, Andrew V. Schally, Jörg B. Engel, Gunhild Keller, Frank Koester, Gabor Halmos, Benjamin Baker, & Stefan Buchholz. (2006). Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations. Proceedings of the National Academy of Sciences of the United States of America, 103(27).
Chicago
Florian Hohla, Elmar Heinrich, Andrew V. Schally, Jörg B. Engel, Gunhild Keller, Frank Koester, Gabor Halmos, Benjamin Baker, and Stefan Buchholz. 2006. “Therapy of Ovarian Cancers with Targeted Cytotoxic Analogs of Bombesin, Somatostatin, and Luteinizing Hormone-Releasing Hormone and Their Combinations.” Proceedings of the National Academy of Sciences of the United States of America 103 (27). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....360f343bf96216d6a676c00600b342ca&authtype=sso&custid=ns315887.